about
Novel lipoproteoplex delivers Keap1 siRNA based gene therapy to accelerate diabetic wound healing.A 35-Year Evolution of Free Flap-Based Breast Reconstruction at a Large Urban Academic Center.The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus.Ex vivo allotransplantation engineering: delivery of mesenchymal stem cells prolongs rejection-free allograft survival.Proximal versus Distal Recipient Vessels in Lower Extremity Reconstruction: A Retrospective Series and Systematic Review.Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.Absence of Rejection in a Facial Allograft Recipient with a Positive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20 Monoclonal Antibody.Diabetes is not associated with increased rates of free flap failure: Analysis of outcomes in 6030 patients from the ACS-NSQIP databaseTopical inhibition of PUMA signaling mitigates radiation injury
P50
Q36341078-A156719C-EE90-4CAB-BC47-13265D8B0782Q40314629-F10E73C2-8404-42D8-8762-25A47DBA4504Q41623135-4575FAC1-EC27-43BE-8705-202849DC72B6Q49851534-72B0C39A-7306-409D-BD8B-87CCAC299C7CQ52602077-71A14B9C-E25E-4DC6-A184-188718AFDD89Q52669381-709BB655-C793-4757-B603-B04AE4BD7FABQ54951741-A35DF17B-7363-4572-91F7-613AC0EE9013Q88543595-1C437194-5E6F-442A-8CE4-6BA169C6AFBDQ91193921-CDC0E093-1714-456D-9FBC-8C65B298D414
P50
description
researcher ORCID ID = 0000-0002-2314-4125
@en
wetenschapper
@nl
name
William J Rifkin
@ast
William J Rifkin
@en
William J Rifkin
@es
William J Rifkin
@nl
type
label
William J Rifkin
@ast
William J Rifkin
@en
William J Rifkin
@es
William J Rifkin
@nl
prefLabel
William J Rifkin
@ast
William J Rifkin
@en
William J Rifkin
@es
William J Rifkin
@nl
P106
P1153
56862092500
P31
P496
0000-0002-2314-4125